New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections
In line with the increase in orthopedic prosthetic surgeries, there has been a significant rise in periprosthetic joint infections (PJI) due to Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria. In case of infection, antibiotic-added spacers are temporarily placed into the periprosthetic r...
Gespeichert in:
Veröffentlicht in: | Journal of the mechanical behavior of biomedical materials 2021-07, Vol.119, p.104496-104496, Article 104496 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 104496 |
---|---|
container_issue | |
container_start_page | 104496 |
container_title | Journal of the mechanical behavior of biomedical materials |
container_volume | 119 |
creator | Tuncer, Kutsi Gür, Bahri Şenol, Onur Aydın, Muhammet Raci Gündoğdu, Ömer |
description | In line with the increase in orthopedic prosthetic surgeries, there has been a significant rise in periprosthetic joint infections (PJI) due to Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria. In case of infection, antibiotic-added spacers are temporarily placed into the periprosthetic region. With the release of antibiotics usually failing to work in fighting off infection, recent studies have centered around developing more effective approaches. New polymethylmethacrylate (PMMA) cement mixtures were prepared for this study with Pluronic®F127, bicarbonate, and citric acid addition. Optimal solutions were searched by monitoring vancomycin release on consecutive days with HPLC in in-vitro. The strengths of the samples were measured via four-point bending tests. Compared to conventional PMMA, strength values were observed to have improved by about 20% with 1.0 g of Pluronic®F127. According to HPLC studies, the highest increase for the area under the curve value was obtained for Pluronic®F127 doped mixture with a value of about 20%. It is understood from SEM and BET studies that addition of Pluronic®F127 helps increase porosity. The present study concludes that the optimum concentration of Pluronic®F127 could improve the strength and drug-releasing capacity of the spacer by increasing its porosity.
[Display omitted]
•It was shown that drug release time was increased with Pluronic®F127 polymer-added bone cement.•It was demonstrated by SEM and BET studies that Pluronic®F127 polymer additive changed the pore structure of cement.•Pluronic®F127 polymer additives were demonstrated by four-point bending tests that increased the strength of bone cement. |
doi_str_mv | 10.1016/j.jmbbm.2021.104496 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2508568760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1751616121001818</els_id><sourcerecordid>2508568760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-c4af8a3c4a25904d2e42cf7e29b30f2ac9a5a02d413859aa86cf2fc212b317043</originalsourceid><addsrcrecordid>eNp9kM9O3DAQh62Kqgu0T1AJ-cgly9jOH-fQQ4WgRULQA5wtxxlrHSXxYnvZ8lI8RJ-s3u6WI6exRt_PM_MR8pXBkgGrL4blMHXdtOTAWe6UZVt_IMdMNrIAJuEov5uKFTWr2YKcxDgA1ABSfiILISTjvIVjgne4pZ2fkRqccE6Rbl1a0V_jJvjZmT-v14w31PpA18GvVy-j_u0i1XNPU0CddhHqLV1jcBmIaYXJGTp4l_tutmiS83P8TD5aPUb8cqin5PH66uHyZ3F7_-Pm8vttYUTVpsKU2kotcuFVC2XPseTGNsjbToDl2rS60sD7kglZtVrL2lhuDWe8E6yBUpyS8_2_eZenDcakJhcNjqOe0W-i4hXIqpZNDRkVe9TktWNAq9bBTTq8KAZq51cN6p9ftfOr9n5z6uwwYNNN2L9l_gvNwLc9gPnMZ4dBReNwNti7kGWo3rt3B_wF37SOfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2508568760</pqid></control><display><type>article</type><title>New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Tuncer, Kutsi ; Gür, Bahri ; Şenol, Onur ; Aydın, Muhammet Raci ; Gündoğdu, Ömer</creator><creatorcontrib>Tuncer, Kutsi ; Gür, Bahri ; Şenol, Onur ; Aydın, Muhammet Raci ; Gündoğdu, Ömer</creatorcontrib><description>In line with the increase in orthopedic prosthetic surgeries, there has been a significant rise in periprosthetic joint infections (PJI) due to Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria. In case of infection, antibiotic-added spacers are temporarily placed into the periprosthetic region. With the release of antibiotics usually failing to work in fighting off infection, recent studies have centered around developing more effective approaches. New polymethylmethacrylate (PMMA) cement mixtures were prepared for this study with Pluronic®F127, bicarbonate, and citric acid addition. Optimal solutions were searched by monitoring vancomycin release on consecutive days with HPLC in in-vitro. The strengths of the samples were measured via four-point bending tests. Compared to conventional PMMA, strength values were observed to have improved by about 20% with 1.0 g of Pluronic®F127. According to HPLC studies, the highest increase for the area under the curve value was obtained for Pluronic®F127 doped mixture with a value of about 20%. It is understood from SEM and BET studies that addition of Pluronic®F127 helps increase porosity. The present study concludes that the optimum concentration of Pluronic®F127 could improve the strength and drug-releasing capacity of the spacer by increasing its porosity.
[Display omitted]
•It was shown that drug release time was increased with Pluronic®F127 polymer-added bone cement.•It was demonstrated by SEM and BET studies that Pluronic®F127 polymer additive changed the pore structure of cement.•Pluronic®F127 polymer additives were demonstrated by four-point bending tests that increased the strength of bone cement.</description><identifier>ISSN: 1751-6161</identifier><identifier>EISSN: 1878-0180</identifier><identifier>DOI: 10.1016/j.jmbbm.2021.104496</identifier><identifier>PMID: 33812290</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Bone cement ; Controlled drug release systems ; Pluronic®F127 ; Staphylococcus aureus ; Vancomycin</subject><ispartof>Journal of the mechanical behavior of biomedical materials, 2021-07, Vol.119, p.104496-104496, Article 104496</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-c4af8a3c4a25904d2e42cf7e29b30f2ac9a5a02d413859aa86cf2fc212b317043</citedby><cites>FETCH-LOGICAL-c359t-c4af8a3c4a25904d2e42cf7e29b30f2ac9a5a02d413859aa86cf2fc212b317043</cites><orcidid>0000-0002-4120-1816 ; 0000-0003-0579-6354</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jmbbm.2021.104496$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33812290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tuncer, Kutsi</creatorcontrib><creatorcontrib>Gür, Bahri</creatorcontrib><creatorcontrib>Şenol, Onur</creatorcontrib><creatorcontrib>Aydın, Muhammet Raci</creatorcontrib><creatorcontrib>Gündoğdu, Ömer</creatorcontrib><title>New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections</title><title>Journal of the mechanical behavior of biomedical materials</title><addtitle>J Mech Behav Biomed Mater</addtitle><description>In line with the increase in orthopedic prosthetic surgeries, there has been a significant rise in periprosthetic joint infections (PJI) due to Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria. In case of infection, antibiotic-added spacers are temporarily placed into the periprosthetic region. With the release of antibiotics usually failing to work in fighting off infection, recent studies have centered around developing more effective approaches. New polymethylmethacrylate (PMMA) cement mixtures were prepared for this study with Pluronic®F127, bicarbonate, and citric acid addition. Optimal solutions were searched by monitoring vancomycin release on consecutive days with HPLC in in-vitro. The strengths of the samples were measured via four-point bending tests. Compared to conventional PMMA, strength values were observed to have improved by about 20% with 1.0 g of Pluronic®F127. According to HPLC studies, the highest increase for the area under the curve value was obtained for Pluronic®F127 doped mixture with a value of about 20%. It is understood from SEM and BET studies that addition of Pluronic®F127 helps increase porosity. The present study concludes that the optimum concentration of Pluronic®F127 could improve the strength and drug-releasing capacity of the spacer by increasing its porosity.
[Display omitted]
•It was shown that drug release time was increased with Pluronic®F127 polymer-added bone cement.•It was demonstrated by SEM and BET studies that Pluronic®F127 polymer additive changed the pore structure of cement.•Pluronic®F127 polymer additives were demonstrated by four-point bending tests that increased the strength of bone cement.</description><subject>Bone cement</subject><subject>Controlled drug release systems</subject><subject>Pluronic®F127</subject><subject>Staphylococcus aureus</subject><subject>Vancomycin</subject><issn>1751-6161</issn><issn>1878-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM9O3DAQh62Kqgu0T1AJ-cgly9jOH-fQQ4WgRULQA5wtxxlrHSXxYnvZ8lI8RJ-s3u6WI6exRt_PM_MR8pXBkgGrL4blMHXdtOTAWe6UZVt_IMdMNrIAJuEov5uKFTWr2YKcxDgA1ABSfiILISTjvIVjgne4pZ2fkRqccE6Rbl1a0V_jJvjZmT-v14w31PpA18GvVy-j_u0i1XNPU0CddhHqLV1jcBmIaYXJGTp4l_tutmiS83P8TD5aPUb8cqin5PH66uHyZ3F7_-Pm8vttYUTVpsKU2kotcuFVC2XPseTGNsjbToDl2rS60sD7kglZtVrL2lhuDWe8E6yBUpyS8_2_eZenDcakJhcNjqOe0W-i4hXIqpZNDRkVe9TktWNAq9bBTTq8KAZq51cN6p9ftfOr9n5z6uwwYNNN2L9l_gvNwLc9gPnMZ4dBReNwNti7kGWo3rt3B_wF37SOfA</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Tuncer, Kutsi</creator><creator>Gür, Bahri</creator><creator>Şenol, Onur</creator><creator>Aydın, Muhammet Raci</creator><creator>Gündoğdu, Ömer</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4120-1816</orcidid><orcidid>https://orcid.org/0000-0003-0579-6354</orcidid></search><sort><creationdate>202107</creationdate><title>New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections</title><author>Tuncer, Kutsi ; Gür, Bahri ; Şenol, Onur ; Aydın, Muhammet Raci ; Gündoğdu, Ömer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-c4af8a3c4a25904d2e42cf7e29b30f2ac9a5a02d413859aa86cf2fc212b317043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bone cement</topic><topic>Controlled drug release systems</topic><topic>Pluronic®F127</topic><topic>Staphylococcus aureus</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tuncer, Kutsi</creatorcontrib><creatorcontrib>Gür, Bahri</creatorcontrib><creatorcontrib>Şenol, Onur</creatorcontrib><creatorcontrib>Aydın, Muhammet Raci</creatorcontrib><creatorcontrib>Gündoğdu, Ömer</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the mechanical behavior of biomedical materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tuncer, Kutsi</au><au>Gür, Bahri</au><au>Şenol, Onur</au><au>Aydın, Muhammet Raci</au><au>Gündoğdu, Ömer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections</atitle><jtitle>Journal of the mechanical behavior of biomedical materials</jtitle><addtitle>J Mech Behav Biomed Mater</addtitle><date>2021-07</date><risdate>2021</risdate><volume>119</volume><spage>104496</spage><epage>104496</epage><pages>104496-104496</pages><artnum>104496</artnum><issn>1751-6161</issn><eissn>1878-0180</eissn><abstract>In line with the increase in orthopedic prosthetic surgeries, there has been a significant rise in periprosthetic joint infections (PJI) due to Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria. In case of infection, antibiotic-added spacers are temporarily placed into the periprosthetic region. With the release of antibiotics usually failing to work in fighting off infection, recent studies have centered around developing more effective approaches. New polymethylmethacrylate (PMMA) cement mixtures were prepared for this study with Pluronic®F127, bicarbonate, and citric acid addition. Optimal solutions were searched by monitoring vancomycin release on consecutive days with HPLC in in-vitro. The strengths of the samples were measured via four-point bending tests. Compared to conventional PMMA, strength values were observed to have improved by about 20% with 1.0 g of Pluronic®F127. According to HPLC studies, the highest increase for the area under the curve value was obtained for Pluronic®F127 doped mixture with a value of about 20%. It is understood from SEM and BET studies that addition of Pluronic®F127 helps increase porosity. The present study concludes that the optimum concentration of Pluronic®F127 could improve the strength and drug-releasing capacity of the spacer by increasing its porosity.
[Display omitted]
•It was shown that drug release time was increased with Pluronic®F127 polymer-added bone cement.•It was demonstrated by SEM and BET studies that Pluronic®F127 polymer additive changed the pore structure of cement.•Pluronic®F127 polymer additives were demonstrated by four-point bending tests that increased the strength of bone cement.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33812290</pmid><doi>10.1016/j.jmbbm.2021.104496</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4120-1816</orcidid><orcidid>https://orcid.org/0000-0003-0579-6354</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1751-6161 |
ispartof | Journal of the mechanical behavior of biomedical materials, 2021-07, Vol.119, p.104496-104496, Article 104496 |
issn | 1751-6161 1878-0180 |
language | eng |
recordid | cdi_proquest_miscellaneous_2508568760 |
source | ScienceDirect Journals (5 years ago - present) |
subjects | Bone cement Controlled drug release systems Pluronic®F127 Staphylococcus aureus Vancomycin |
title | New bone cements with Pluronic®F127 for prophylaxis and treatment of periprosthetic joint infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A05%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20bone%20cements%20with%20Pluronic%C2%AEF127%20for%20prophylaxis%20and%20treatment%20of%20periprosthetic%20joint%20infections&rft.jtitle=Journal%20of%20the%20mechanical%20behavior%20of%20biomedical%20materials&rft.au=Tuncer,%20Kutsi&rft.date=2021-07&rft.volume=119&rft.spage=104496&rft.epage=104496&rft.pages=104496-104496&rft.artnum=104496&rft.issn=1751-6161&rft.eissn=1878-0180&rft_id=info:doi/10.1016/j.jmbbm.2021.104496&rft_dat=%3Cproquest_cross%3E2508568760%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2508568760&rft_id=info:pmid/33812290&rft_els_id=S1751616121001818&rfr_iscdi=true |